Independent register of U.S. FDA drug recalls · updated Oct 11, 2026
RxRecalls Get alerts

FDA Drug Recalls

6,161 recalls · Class II, newest first

Class II · Moderate risk

Sterile Cannabidiol

Lack of Assurance of Sterility and Marketed without an approved NDA/ANDA: Product contains unapproved Cannabidiol and Curcumin

Terminated Sterility / contamination BIOTA Biosciences LLC D-1326-2020
Class II · Moderate risk

Methotrexate

Lack of Assurance of Sterility; the media used to conduct post-compounding sterility testing for the Methotrexate product was expired.

Terminated Sterility / contamination Edge Pharma, LLC D-0226-2021
Class II · Moderate risk

ePHEDrine Sulfate

Firm is recalling 46 lots of various products because of a lack of sterility assurance.

Terminated Sterility / contamination PharMEDium Services, LLC NDC 71030-003-09 D-1088-2020
Class II · Moderate risk

rocuronium Bromide

Firm is recalling 46 lots of various products because of a lack of sterility assurance.

Terminated Sterility / contamination PharMEDium Services, LLC NDC 71019-321-05 D-1087-2020
Class II · Moderate risk

nICARdipine HCl

Firm is recalling 46 lots of various products because of a lack of sterility assurance.

Terminated Sterility / contamination PharMEDium Services, LLC NDC 71019-206-01 D-1082-2020
Class II · Moderate risk

ePHEDrine Sulfate

Firm is recalling 46 lots of various products because of a lack of sterility assurance.

Terminated Sterility / contamination PharMEDium Services, LLC NDC 71030-003-12 D-1081-2020
Class II · Moderate risk

*Mitomycin 0.04% Ophth DR eye drops

Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.

Terminated Sterility / contamination Medical Center Pharmacy, Inc. NDC 67457-0518-05 D-1077-2020
Class II · Moderate risk

*Morphine 2 mg/mL Cassette

Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.

Terminated Sterility / contamination Medical Center Pharmacy, Inc. NDC 00409-1134-03 D-1075-2020

Recalls by year